Docs still value rep interaction: study

Share this article:
Despite the rapid growth of alternative channels and slashing of field forces industrywide, physicians continue to rely on pharmaceutical sales reps for the knowledge they provide on their products and disease states, a recent study shows.

According to the Detailing Quality and Relationship Study, conducted by private market research firm The Joy Scott Group, an average of 85% of physicians from across 25 specialties said a sales rep’s knowledge about a specific disease state dramatically affects the their confidence in prescribing a drug.

“The doctors like to see a face, especially if they have a question,” Joy Scott, CEO of The Joy Scott Group, told MM&M. “The doctors also liked to be asked questions such as ‘how is that new diabetes drug working on your senior population that also has cardiovascular problems?’”

Scott said that as part of the study, physicians were specifically asked, “Absent of anything new to inform you, how would you suggest a representative could make the best use of your time?” A predictable response might be, “Leave drug samples and go.” Scott said. But this is not what the study found in its verbatim responses from the 5,000 surveyed doctors.

“Instead physicians and their office staff need and want more information with Medicare Part D, patient assistance programs, patient compliance issues and objective patient information services,” Scott said.

Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...